BIOA

BioAge Labs, Inc. - Common Stock (BIOA)

About BioAge Labs, Inc. - Common Stock (BIOA)

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.

Details

Daily high

$4.48

Daily low

$4.18

Price at open

$4.21

52 Week High

$26.62

52 Week Low

$2.88

Market cap

151.6M

Dividend yield

0.00%

Volume

319,949

Avg. volume

378,543

P/E ratio

-2.06

BioAge Labs, Inc. - Common Stock News